Febutaz 20mg Tablet contains Febuxostat, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid in the body, thereby helping to prevent gout attacks and complications associated with elevated uric acid levels such as tophi formation and kidney stones. Febutaz is typically prescribed for adults who have not responded adequately to other urate-lowering therapies or who are intolerant to them. The 20mg dosage is often used as a starting dose, with adjustments made based on serum uric acid levels and clinical response. Patients are advised to take the tablet orally, usually once daily, with or without food, and to maintain adequate hydration to support kidney function. Common side effects may include nausea, joint pain, and rash, while serious adverse effects are rare but can include liver function abnormalities and cardiovascular events. Regular monitoring of liver enzymes and renal function is recommended during treatment. Febutaz should be used cautiously in patients with pre-existing liver or cardiovascular conditions and is contraindicated in those with hypersensitivity to Febuxostat. Always consult a healthcare professional before starting or adjusting the dosage.